This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mynott, T. L.
Right arrow Articles by Prathalingam, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mynott, T. L.
Right arrow Articles by Prathalingam, S. R.

 Previous Article  |  Next Article 

Infection and Immunity, January 2002, p. 86-95, Vol. 70, No. 1
0019-9567/01/$04.00+0     DOI: 10.1128/IAI.70.1.86-95.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Proteolytic Inhibition of Salmonella enterica Serovar Typhimurium-Induced Activation of the Mitogen-Activated Protein Kinases ERK and JNK in Cultured Human Intestinal Cells

Tracey L. Mynott,1* Ben Crossett,1 and S. Radhika Prathalingam1

Center for Molecular Microbiology and Infection, Imperial College of Science, Technology and Medicine, London, United Kingdom1

Received 6 June 2001/ Returned for modification 27 August 2001/ Accepted 18 October 2001

Bromelain, a mixture of cysteine proteases from pineapple stems, blocks signaling by the mitogen-activated protein (MAP) kinases extracellular regulated kinase 1 (ERK-1) and ERK-2, inhibits inflammation, and protects against enterotoxigenic Escherichia coli infection. In this study, we examined the effect of bromelain on Salmonella enterica serovar Typhimurium infection, since an important feature of its pathogenesis is its ability to induce activation of ERK-1 and ERK-2, which leads to internalization of bacteria and induction of inflammatory responses. Our results show that bromelain dose dependently blocks serovar Typhimurium-induced ERK-1, ERK-2, and c-Jun NH2-terminal kinase (JNK) activation in Caco-2 cells. Bromelain also blocked signaling induced by carbachol and anisomycin, pharmacological MAP kinase agonists. Despite bromelain inhibition of serovar Typhimurium-induced MAP kinase signaling, it did not prevent subsequent invasion of the Caco-2 cells by serovar Typhimurium or alter serovar Typhimurium -induced decreases in resistance across Caco-2 monolayers. Surprisingly, bromelain also did not block serovar Typhimurium-induced interleukin-8 (IL-8) secretion but synergized with serovar Typhimurium to enhance IL-8 production. We also found that serovar Typhimurium does not induce ERK phosphorylation in Caco-2 cells in the absence of serum but that serovar Typhimurium-induced invasion and decreases in monolayer resistance are unaffected. Collectively, these data indicate that serovar Typhimurium-induced invasion of Caco-2 cells, changes in the resistance of epithelial cell monolayers, and IL-8 production can occur independently of the ERK and JNK signaling pathways. Data also confirm that bromelain is a novel inhibitor of MAP kinase signaling pathways and suggest a novel role for proteases as inhibitors of signal transduction pathways in intestinal epithelial cells.


* Corresponding author. Mailing address: Center for Molecular Microbiology and Infection, Imperial College of Science, Technology and Medicine, Flower’s Building, Armstrong Rd., London SW7 2AZ, United Kingdom. Phone: 44 20 7594 5299. Fax: 44 20 7594 5299. E-mail: t.mynott{at}ic.ac.uk.

Editor: V. J. DiRita


Infection and Immunity, January 2002, p. 86-95, Vol. 70, No. 1
0019-9567/01/$04.00+0     DOI: 10.1128/IAI.70.1.86-95.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Voth, D. E., Heinzen, R. A. (2009). Sustained Activation of Akt and Erk1/2 Is Required for Coxiella burnetii Antiapoptotic Activity. Infect. Immun. 77: 205-213 [Abstract] [Full Text]  
  • Reissinger, A., Skinner, J. A., Yuk, M. H. (2005). Downregulation of Mitogen-Activated Protein Kinases by the Bordetella bronchiseptica Type III Secretion System Leads to Attenuated Nonclassical Macrophage Activation. Infect. Immun. 73: 308-316 [Abstract] [Full Text]  
  • Haque, A, Bowe, F, Fitzhenry, R J, Frankel, G, Thomson, M, Heuschkel, R, Murch, S, Stevens, M P, Wallis, T S, Phillips, A D, Dougan, G (2004). Early interactions of Salmonella enterica serovar typhimurium with human small intestinal epithelial explants. Gut 53: 1424-1430 [Abstract] [Full Text]  
  • Zhang, J., Li, H., Wang, J., Dong, Z., Mian, S., Yu, F.-S. X. (2004). Role of EGFR Transactivation in Preventing Apoptosis in Pseudomonas aeruginosa-Infected Human Corneal Epithelial Cells. IOVS 45: 2569-2576 [Abstract] [Full Text]  
  • Chung, W. O., Dale, B. A. (2004). Innate Immune Response of Oral and Foreskin Keratinocytes: Utilization of Different Signaling Pathways by Various Bacterial Species. Infect. Immun. 72: 352-358 [Abstract] [Full Text]  
  • Berkes, J, Viswanathan, V K, Savkovic, S D, Hecht, G (2003). Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439-451 [Abstract] [Full Text]